Clinical Trial: Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Safety and Efficacy Study of Neural Progenitor Cell Transplantation and Paracrine Factors From Human Mesenchymal Stem Cells to Treat Newborn With Hypoxic-ischemic Encephalopathy<

Brief Summary: The purpose of this study is to investigate the efficacy and safety of allogenic neural progenitor cell and paracrine factors of human mesenchymal stem cells for patients with moderate/severe Hypoxic-Ischemic Encephalopathy